Table 1.
Clinical presentation of the 172 symptomatic individuals with mild COVID-19a
| n (%) | |
|---|---|
| Age, median (IQR), years | 26 (22–47) |
| Male sex | 66 (38.4) |
| Fever (>37.5°C) | 20 (11.6) |
| Cough | 69 (40.1) |
| Sputum | 68 (39.5) |
| Hyposmiab | 68 (39.5) |
| Nasal congestion | 59 (34.3) |
| Hypogeusia | 58 (33.7) |
| Myalgia | 54 (31.4) |
| Headache | 54 (31.4) |
| Fatigue | 46 (26.7) |
| Rhinorrhoea | 45 (26.2) |
| Dizziness | 32 (18.6) |
| Chills | 31 (18.0) |
| Sore throat | 31 (18.0) |
| Diarrhoea | 27 (15.7) |
| Anorexia | 23 (13.4) |
| Dyspnoea | 7 (4.1) |
| Nausea | 7 (4.1) |
| Abdominal pain | 5 (2.9) |
| Pleuritic chest pain | 3 (1.7) |
| Vomiting | 2 (1.2) |
| Haemoptysis | 1 (0.6) |
| Time from initial symptoms to diagnosis, median (IQR), days | 14 (8–17) |
| Time from diagnosis to admission, median (IQR), days | 3 (3–6) |
COVID-19, coronavirus disease 2019; IQR, interquartile range.
a
Of 213 participating individuals, 41 asymptomatic individuals were excluded from the analysis.
b
Among 68 individuals with hyposmia, 32 (47.1%) complained of having nasal congestion.